Brian Miller: Clinical Trials

3 trials sponsored by Brian Miller, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Completed 1
Phase 21Unknown 1

Follow Brian Miller: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tocilizumab in Schizophrenia
Tocilizumab, Normal saline - Schizophrenia, Psychotic Disorders
Phase 1UnknownBrian Miller202016-09-012023-07-21
Siltuximab in Schizophrenia
Siltuximab, normal saline - Schizophrenia, Psychotic Disorders
Phase 1 / Phase 2UnknownBrian Miller302016-05-012023-07-21
An Open-Label Trial of Tocilizumab in Schizophrenia
Tocilizumab - Schizophrenia
Phase 1CompletedBrian Miller82012-09-012021-07-29

Conditions studied

Schizophrenia (3)  ·  Inflammation (2)  ·  Psychotic Disorders (2)

Interventions

Saline Solution (2)  ·  tocilizumab (2)  ·  siltuximab (1)

Countries

United States (3)

Top investigators

Brian J Miller, MD (1)